Development and research progress of anti-drug resistant fungal drugs
With the widespread use of immunosuppressive agents and the increase in patients with severe infections, the incidence of fungal infections worldwide has increased year by year. The fungal pathogens Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus cause a total of more than 1 mill...
Main Authors: | Xiangyi Cui, Lanlin Wang, Yuhong Lü, Changwu Yue |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Journal of Infection and Public Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034122002064 |
Similar Items
-
Fungal Drug Response and Antimicrobial Resistance
by: Paloma Osset-Trénor, et al.
Published: (2023-05-01) -
Antifungals and Drug Resistance
by: Chowdhury Mobaswar Hossain, et al.
Published: (2022-10-01) -
Immunotherapy and Antifungal Drugs of Candidiasis: Achievements and Challenges
by: leili Aghebati-Maleki, et al.
Published: (2021-10-01) -
Fungal Spectrum and Susceptibility Against Nine Antifungal Agents in 525 Deep Fungal Infected Cases
by: Cai W, et al.
Published: (2023-07-01) -
Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway
by: Kyle McEvoy, et al.
Published: (2020-08-01)